Itaconic Acid Biosynthesis in Cupriavidus necator
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing itaconic acid in E. coli face challenges such as low yields due to protein aggregation, growth defects, and inefficient metabolic flux, with existing strategies like temperature adjustments and genetic modifications not fully addressing these issues.
Innovation Solution
Engineering Cupriavidus necator to express cis-aconitate decarboxylase, citrate synthase, and aconitate hydratase enzymes, along with metabolic modifications to enhance itaconic acid production by altering metabolic flux and reducing degradation, thereby increasing yields and overcoming previous limitations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If E. coli is engineered to produce itaconic acid using heterologous expression of cad1, then itaconic acid production is achieved, but protein aggregation occurs resulting in low yields
Solution Approach 1:
The patent extracts the problematic cad1 gene from Aspergillus terreus and transfers it to E. coli, but the foreign protein causes aggregation. The solution involves removing the problematic heterologous enzyme and replacing it with endogenous E. coli enzymes (acnB and icd) that naturally catalyze the required reactions without aggregation issues, thus extracting the problematic element while retaining the desired metabolic pathway.
Solution Approach 2:
The patent changes the enzymatic parameters by substituting the heterologous Cad1 enzyme with native E. coli enzymes acnB and icd. This parameter change transforms the system from relying on a foreign protein prone to aggregation to using indigenous proteins optimized for E. coli cellular conditions, thereby improving reliability while maintaining itaconic acid production.
2Quantity of substance
If metabolic flux is redirected towards itaconic acid production by deleting icd1, then itaconic acid titers increase, but growth defects occur
Solution Approach 1:
Instead of completely deleting icd1 which causes growth defects, the patent uses partial inhibition strategies such as conditional expression or regulated enzyme activity. This allows sufficient flux redirection toward itaconic acid production during specific growth phases while maintaining adequate isocitrate dehydrogenase activity for essential metabolic functions, thus achieving high titers without severe growth penalties.
Solution Approach 2:
The patent implements dynamic control of metabolic flux through inducible promoters or phase-dependent gene expression. During exponential growth phase, normal TCA cycle function is maintained for cell proliferation. Upon induction or entry into stationary phase, the metabolic flux is dynamically redirected toward itaconic acid production, allowing both good growth and high product titers at different time points.
3Reliability
If temperature is reduced to prevent protein aggregation, then protein stability improves, but overall production efficiency decreases
Solution Approach 1:
The patent employs E. coli's own native enzymes (acnB and icd) that are naturally adapted to grow at standard temperatures (37°C). These endogenous proteins self-regulate their stability and activity under physiological conditions, eliminating the need for temperature reduction. The system serves itself by using proteins evolved for the host's native temperature, thereby maintaining both stability and high production efficiency.
4Quantity of substance
If multiple genetic modifications are introduced to enhance itaconic acid production, then metabolic flux improvement is achieved, but system complexity increases
Solution Approach 1:
The patent utilizes E. coli's existing metabolic pathways and native enzymes that serve multiple functions. The acnB enzyme not only catalyzes cis-aconitate conversion but is part of the natural TCA cycle already optimized for E. coli metabolism. This multi-functionality approach allows metabolic flux redirection without introducing separate dedicated enzymes, thereby improving flux while minimizing genetic complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The approach significantly enhances itaconic acid production in Cupriavidus necator, achieving higher titers and improving metabolic efficiency compared to previous methods, demonstrating a robust biosynthetic pathway for increased bio-based chemical production.
Implementation Method 1
This enzyme converts cis-aconitate from the TCA cycle into itaconic acid
Implementation Method 2
The TCA cycle comprises nine biochemical reactions carried out by eight enzymes to generate energy from acetyl-CoA
Implementation Method 3
The TCA cycle comprises nine biochemical reactions carried out by eight enzymes
Data Source
AI summary
Methods and materials for the production of compounds involved in the TCA cycle, and/or derivatives thereof and/or compounds related thereto are provided. Also provided are products produced in accordance with these methods and materials.